Follow
Bylgja Hilmarsdóttir
Bylgja Hilmarsdóttir
Landspitali University Hospital, Iceland
Verified email at landspitali.is
Title
Cited by
Cited by
Year
Endothelial induced EMT in breast epithelial cells with stem cell properties
V Sigurdsson, B Hilmarsdottir, H Sigmundsdottir, AJR Fridriksdottir, ...
PloS one 6 (9), e23833, 2011
1232011
HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR
S Ingthorsson, K Andersen, B Hilmarsdóttir, GM Mælandsmo, ...
Oncogene 35 (32), 4244-4255, 2016
842016
Functional role of the microRNA-200 family in breast morphogenesis and neoplasia
B Hilmarsdottir, E Briem, JT Bergthorsson, MK Magnusson, T Gudjonsson
Genes 5 (3), 804-820, 2014
552014
Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition
S Halldorsson, N Rohatgi, M Magnusdottir, KS Choudhary, T Gudjonsson, ...
Cancer Letters 396, 117-129, 2017
522017
Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer
MT Grinde, B Hilmarsdottir, HM Tunset, IM Henriksen, J Kim, MH Haugen, ...
Breast Cancer Research 21 (1), 1-13, 2019
362019
Clinical phenotype in heterozygote and biallelic B ernard‐S oulier syndrome—A case control study
G Bragadottir, ER Birgisdottir, BR Gudmundsdottir, B Hilmarsdottir, ...
American journal of hematology 90 (2), 149-155, 2015
292015
Tyrosine kinase mutations in gastrointestinal stromal tumors in a nation‐wide study in Iceland
G Tryggvason, B Hilmarsdottir, GH GUNNARSSON, JJ Jonsson, ...
Apmis 118 (9), 648-656, 2010
292010
MicroRNA-200c-141 and∆ Np63 are required for breast epithelial differentiation and branching morphogenesis
B Hilmarsdóttir, E Briem, V Sigurdsson, SR Franzdóttir, M Ringnér, ...
Developmental biology 403 (2), 150-161, 2015
282015
O-GlcNAc transferase inhibition differentially affects breast cancer subtypes
A Barkovskaya, K Seip, B Hilmarsdottir, GM Maelandsmo, SA Moestue, ...
Scientific reports 9 (1), 1-11, 2019
212019
Application of the D492 cell lines to explore breast morphogenesis, EMT and cancer progression in 3D culture
E Briem, S Ingthorsson, GA Traustadottir, B Hilmarsdottir, T Gudjonsson
Journal of mammary gland biology and neoplasia 24 (2), 139-147, 2019
202019
Expression and functional role of sprouty-2 in breast morphogenesis
V Sigurdsson, S Ingthorsson, B Hilmarsdottir, SM Gustafsdottir, ...
PloS one 8 (4), e60798, 2013
182013
ECM1 secreted by HER2-overexpressing breast cancer cells promotes formation of a vascular niche accelerating cancer cell migration and invasion
SS Steinhaeuser, E Morera, Z Budkova, A Schepsky, Q Wang, O Rolfsson, ...
Laboratory Investigation 100 (7), 928-944, 2020
172020
Inhibition of PTP1B disrupts cell–cell adhesion and induces anoikis in breast epithelial cells
B Hilmarsdottir, E Briem, S Halldorsson, J Kricker, S Ingthorsson, ...
Cell death & disease 8 (5), e2769-e2769, 2017
172017
MiR-203a is differentially expressed during branching morphogenesis and EMT in breast progenitor cells and is a repressor of peroxidasin
E Briem, Z Budkova, AK Sigurdardottir, B Hilmarsdottir, J Kricker, W Timp, ...
Mechanisms of Development 155, 34-47, 2019
122019
Expression of ncRNAs on the DLK1-DIO3 locus is associated with basal and mesenchymal phenotype in breast epithelial progenitor cells
Z Budkova, AK Sigurdardottir, E Briem, JT Bergthorsson, S Sigurdsson, ...
Frontiers in cell and developmental biology 8, 461, 2020
112020
The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows …
A Arason, BA Agnarsson, G Johannesdottir, OT Johannsson, ...
Genes 10 (11), 882, 2019
82019
Context-dependent function of myoepithelial cells in breast morphogenesis and neoplasia
S Ingthorsson, B Hilmarsdottir, J Kricker, MK Magnusson, T Gudjonsson
Current molecular biology reports 1 (4), 168-174, 2015
82015
Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways
A Amirfallah, H Knutsdottir, A Arason, B Hilmarsdottir, OT Johannsson, ...
PloS one 16 (11), e0260327, 2021
72021
Detection of phenotype‐specific therapeutic vulnerabilities in breast cells using a CRISPR loss‐of‐function screen
A Barkovskaya, CM Goodwin, K Seip, B Hilmarsdottir, S Pettersen, ...
Molecular Oncology 15 (8), 2026-2045, 2021
32021
Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer
ST Karvelsson, Q Wang, B Hilmarsdottir, A Sigurdsson, SA Moestue, ...
NPJ systems biology and applications 7 (1), 1-10, 2021
22021
The system can't perform the operation now. Try again later.
Articles 1–20